19 June 2013
Keywords: az, merck, co, develop, early-stage, cancer, drugs
Article | 02 June 2009
Anglo-Swedish drug major AstraZeneca and the USA's Merck & Co have signed an accord to develop a cocktail of cancer drugs ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 June 2009
1 June 2009
© 2013 thepharmaletter.com